GENEREX BIOTECHNOLOGY ANNOUNCES U.S. DISTRIBUTION OF NEW GLUCOSE RAPIDSPRAY PRODUCT

Generex Biotechnology Corporation, the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced that Cardinal Health will distribute its new Glucose RapidSpray product in the U.S. Glucose RapidSpray is expected to be in stores by October, 2006.

BioSpace (http://www.marketwire.com/mw/release_html_pressroom?id=F65B254181F3F030&release_id=163836)